Research Overview

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) covers innovations in therapeutics development and improvement of adherence for asthma and other obstructive respiratory diseases. It also covers emerging therapeutic modalities for neurological diseases, including orally delivered small molecules, disease modifying therapies for Alzheimer’s and other neurodegenerative diseases. Further, innovations in RNA therapeutics and developments in delivery of RNAi have been discussed. A few innovations covering obesity management and personalized obesity diagnosis based on phenotype are also covered.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.